Evidence map›Paper›PMID 40729632›Full record

Trial reportJMIR formative research2025

Exploratory Impact of iCARE Nigeria, a Combined mHealth and Peer Navigation Intervention, on Depressive Symptoms and Substance Use Among Youth Living With HIV in Nigeria: Single-Arm Trial.

Olusegun Ayomikun Ogunmola, Rita Frinue Tamambang, Kehinde Kuti, Lisa M Kuhns, Olutosin Awolude, Adedotun Adetunji, Bibilola Oladeji, Oladayo Olaleye, Adeola Mary Oyerinde, Robert Garofalo and 2 more

Abstract readClinical Trial
In one paragraph

Trial report in JMIR formative research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. An Evidence-Based Approach to Facilitating PrEP Initiation Among YMSM: The MyPEEPS Plus mHealth and E-Peer Navigation Intervention.AIDS education and prevention : official publication of the International Society for AIDS Education · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Olusegun Ayomikun OgunmolaCentre for Child and Adolescent Mental Health, College of Medicine, University of Ibadan, Ibadan, Nigeria.ORCID 0000-0003-4382-0044
Rita Frinue TamambangCentre for Child and Adolescent Mental Health, College of Medicine, University of Ibadan, Ibadan, Nigeria.ORCID 0000-0002-6632-9090
Kehinde KutiInfectious Disease Institute, College of Medicine, University of Ibadan, Ibadan, Nigeria.ORCID 0000-0001-7472-7198
Lisa M KuhnsDepartment of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.ORCID 0000-0001-8294-7801
Olutosin AwoludeInfectious Disease Institute, College of Medicine, University of Ibadan, Ibadan, Nigeria.ORCID 0000-0003-3365-0256
Adedotun AdetunjiDepartment of Family Medicine, University College Hospital, Ibadan, Ibadan, Nigeria.ORCID 0000-0003-1589-6228
Bibilola OladejiDepartment of Psychiatry, College of Medicine, University of Ibadan, University College Hospital premises, Queen Elizabeth II Road, Ibadan, 200212, Nigeria, 234 8132243158.ORCID 0000-0001-5856-2100
Oladayo OlaleyeInfectious Disease Institute, College of Medicine, University of Ibadan, Ibadan, Nigeria.ORCID 0009-0008-7470-906X
Adeola Mary OyerindeInfectious Disease Institute, College of Medicine, University of Ibadan, Ibadan, Nigeria.ORCID 0009-0005-6632-3237
Robert GarofaloDepartment of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.ORCID 0000-0001-9513-9416
Babafemi TaiwoDivision of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.ORCID 0000-0003-2661-9103
Olayinka Olusola OmigbodunCentre for Child and Adolescent Mental Health, College of Medicine, University of Ibadan, Ibadan, Nigeria.ORCID 0000-0003-3808-8530

Funding

Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
Multidisciplinary NeuroAIDS Research Training to Improve HIV Outcomes in NigeriaD43TW009608 · FIC · NORTHWESTERN UNIVERSITY AT CHICAGO · PI PHILIP B GORELICK, Olayinka Olusola Omigbodun · 2013 to 2026
$3.9M
Intensive Combination Approach to Rollback the Epidemic (iCARE) in Nigerian AdolescentsUG3HD096920 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GAROFALO, ROBERT, TAIWO, BABAFEMI O · 2018 to 2020
$2.0M
FIC NIH HHS D43 TW009608NCATS NIH HHS UL1 TR001422NICHD NIH HHS UG3 HD096920
6 · The paper itself

Abstract

Background: Mental health problems are a barrier to the well-being of youth living with HIV. Many youth living with HIV in Nigeria face peculiar biopsychosocial vulnerabilities that predispose them to mental health problems including depression and substance use. In addition to improving treatment outcomes like medication adherence and linkage to care, peer engagement has shown some promise in improving the social and emotional well-being of this population. Mobile health (mHealth) interventions like SMS text messaging medication reminders may also contribute to better outcomes in youth living with HIV. Emerging evidence suggests that combination interventions may be more effective than single interventions in improving key HIV testing and treatment outcomes among youth in Nigeria. Objective: This study aims to explore the impact of Intensive Combination Approach to Rollback the Epidemic in Nigerian Adolescents (iCARE Nigeria) study-an mHealth and peer navigation intervention primarily aimed at medication adherence and viral suppression-on depressive symptoms and substance use among youth living with HIV in Nigeria. Methods: A single-arm clinical trial was conducted at the Infectious Disease Institute, College of Medicine, University of Ibadan, Nigeria- primarily to improve medication adherence and viral suppression among youth living with HIV attending its HIV clinic. The intervention combined peer navigation and daily, 2-way, text message medication reminders delivered over a period of 48 weeks. Participants were screened at baseline and follow-up visits (24 and 48 weeks) for depression and substance use using standardized measures. Paired t tests and McNemar tests were used to investigate the change in depressive symptoms and the change in the proportion of participants reporting substance use over time, respectively. Results: All 40 enrolled participants (n=20, 50% male; mean age 19.9 y, SD 2.5 y) completed baseline and follow-up visits at week 24, while 37 (92.5%) participants completed the week 48 visit. Compared with baseline, there were significantly fewer self-reported depressive symptoms observed at 48 weeks (mean 2.89 vs 2.08; t36=2.04, 95% CI 0.006-1.615) but not at 24 weeks (mean 2.89 vs 2.62; t36=0.47, 95% CI -0.74 to 1.44). There were fewer self-reports of substance use at weeks 24 and 48 when compared to baseline, but these were not statistically significant (odds ratio [OR] ∞, 95% CI 0.189-∞ and OR 3.0, 95% CI 0.24-157.49, respectively). Conclusions: These findings suggest a statistically significant reduction in depressive symptoms among youth living with HIV over the 48-week intervention period that may be due to the iCARE Nigeria intervention. However, given limitations such as low levels of depressive symptoms at baseline, small sample size, and the lack of a control group, future studies such as the randomized stepped wedge evaluation of the iCARE intervention are needed to provide better insights into these exploratory findings.

Indexed as

DepressionHIV InfectionsPeer GroupSubstance-Related DisordersAdolescentFemaleHumansMaleMedication AdherenceNigeriaTelemedicineText MessagingYoung Adultcell phonesdepressionHIV/AIDSmental healthNigeriapeerSMSsubstance usewell-beingyouth

Identifiers

PMID40729632
PMCPMC12306911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.